Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-043682
Filing Date
2025-05-15
Accepted
2025-05-15 07:30:49
Documents
80
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0242099-10q_incannex.htm   iXBRL 10-Q 662362
2 CERTIFICATION ea024209901ex31-1_incannex.htm EX-31.1 11045
3 CERTIFICATION ea024209901ex31-2_incannex.htm EX-31.2 10849
4 CERTIFICATION ea024209901ex32-1_incannex.htm EX-32.1 4228
5 CERTIFICATION ea024209901ex32-2_incannex.htm EX-32.2 4594
  Complete submission text file 0001213900-25-043682.txt   4705639

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ixhl-20250331.xsd EX-101.SCH 48309
7 XBRL CALCULATION FILE ixhl-20250331_cal.xml EX-101.CAL 40434
8 XBRL DEFINITION FILE ixhl-20250331_def.xml EX-101.DEF 201499
9 XBRL LABEL FILE ixhl-20250331_lab.xml EX-101.LAB 390063
10 XBRL PRESENTATION FILE ixhl-20250331_pre.xml EX-101.PRE 218138
83 EXTRACTED XBRL INSTANCE DOCUMENT ea0242099-10q_incannex_htm.xml XML 505848
Mailing Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153
Business Address 8 CENTURY CIRCUIT STE. 105 NORWEST NSW C3 2153 61 409 840 786
Incannex Healthcare Inc. (Filer) CIK: 0001873875 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-41106 | Film No.: 25948717
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)